Alkermes is a biopharmaceutical company that applies neuroscience expertise to develop medicines for psychiatric and neurological disorders. Its focus includes conditions that are complex and difficult to treat, such as addiction, serious mental illness, and sleep disorders.
The company operates in the biotechnology and pharmaceuticals industries. Its stated culture emphasizes empathy for patients and their families, collaboration among employees, and a sense of urgency in its work to create new treatment options.
